ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1

Feng Xiao Jun; Gao Hui; Gao Si; Li Zhuoming; Li Hong; Lu Jing; Wang Jiao Jiao; Huang Xiao Yang; Liu Min; Zou Jian; Ye Jian Tao; Liu Pei Qing*吉首大学
British Journal of Pharmacology2015-6DOI: 10.1111/bph.13091
12阅读
引用收藏
分享

摘要

Background and PurposeThe orphan nuclear receptor NOR1 belongs to the NR4A subfamily of the nuclear hormone receptor superfamily, and is involved in glucose and fat metabolism. However, its potential contribution to cardiovascular diseases remains to be assessed. Here, the roles of NOR1 in cardiac hypertrophy induced by isoprenaline and the underlying molecular mechanisms were investigated. <br>Experimental ApproachNOR1 was expressed in cardiomyocytes treated with isoprenaline. After NOR1 overexpression or knockdown in neonatal rat cardiomyocytes, cellular hypertrophy was monitored by measuring cell surface area and the mRNA of hypertrophic biomarkers. Interactions between NOR1 and PARP-1 were investigated by co-immunoprecipitation. NOR1 expression and PARP-1 activity were measured in rats with cardiac hypertrophy induced by isoprenaline. <br>Key ResultsTreatment with isoprenaline significantly up-regulated NOR1 expression and PARP-1 activity both in vivo and in vitro. Specific gene silencing of NOR1 attenuated isoprenaline-induced cardiomyocyte hypertrophy, whereas NOR1 overexpression exacerbated cardiac hypertrophy. We identified a physical interaction between NOR1 and PARP-1, which was enhanced by NOR1 transfection and thereby led to PARP-1 activation. Overexpression of NOR1, but not C293Y, a NOR1 mutant lacking the PARP-1 binding activity, increased cellular surface area and the mRNA levels of atrial natriuretic factor and brain natriuretic polypeptide, effects blocked by the PARP-1 inhibitor 3-aminobenzamide or siRNA for PARP-1. <br>Conclusions and ImplicationsThis is the first evidence that NOR1 was involved in isoprenaline-induced cardiac hypertrophy. The pro-hypertrophic effect of NOR1 can be partly attributed to its regulation of PARP-1 enzymic activity.

相关
加载中…
  • PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1
    Geng Biao; Cai Yi; Gao Si; Lu Jing; Zhang Lu; Zou Jian; Liu Min; Yu Shanshan; Ye Jiantao*; Liu PeiqingBiochemical and Biophysical Research Communications, 2013, 430(3): 944-950.被引 8
  • AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy
    Liu Min; Li Zhe; Chen Guo Wen; Li Zhuo Ming; Wang Lu Ping; Ye Jian Tao*; Luo Hai Bin; Liu Pei QingMolecular and Cellular Endocrinology, 2014, 392(1-2): 14-22.被引 3
  • NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
    Guo, Ningning; Zheng, Di; Sun, Jiaxin; Lv, Jian; Wang, Shun; Fang, Yu; Zhao, Zhenyi; Zeng, Sai; Guo, Qiuxiao; Tong, Jingjing*; Wang, Zhihua*Frontiers in Cardiovascular Medicine, 2021, 8: 791501.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
British Journal of Pharmacology
发表日期
2015-06
卷期
第 172 卷, 第 11 期
页码
2852-2863
DOI
10.1111/bph.13091
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
National Natural Science Foundation of China [81072641, 81273499, 81200096]; National Science and Technology Major Project of China 'Key New Drug Creation and Manufacturing Program' [2011ZX09401-307]; Team item of Natural Science Foundation of Guangdong Province [S2011030003190]; Major Project of Department of Education of Guangdong Province [CXZD1006]

作者

  • F

    Feng Xiao Jun (第一作者)

  • G

    Gao Hui

    jishou univ

查看全部 12 位作者收起作者
  • G

    Gao Si

  • L

    Li Zhuoming

  • L

    Li Hong

  • L

    Lu Jing

  • W

    Wang Jiao Jiao

  • H

    Huang Xiao Yang

  • L

    Liu Min

  • Z

    Zou Jian

  • Y

    Ye Jian Tao

  • L

    Liu Pei Qing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417